Precise, Controlled Delivery
Engineered for uniform, controlled delivery to specific depths in the skin for a wide range of treatments
Greater Access
Shelf-stable treatments eliminate the need for refrigeration, improve access enabling direct-to-customer (D2C) distribution and market expansion
Technology Enhanced Platform
Designed for ease-of-use and better adherence via integrated treatment tracking
Targeting Large, Attractive Markets
Current markets are constrained by existing delivery methods, underestimating the true size and growth potential. Protected by a robust IP portfolio, Panther is bringing innovation to massive markets.
$49Bn
Clinical Skincare
$220Bn
Oncology
$77.3Bn
Longevity/Anti-Aging
$4.6Bn
Dermal Fillers
Engineered For Superior Outcomes
Our innovative approach bridges the gap between scientific discovery and engineered solutions. Panther does not develop new compounds; we engineer superior delivery of already proven treatments.